inpefa
Generic: sotagliflozin
Labeler: lexicon pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
inpefa
Generic Name
sotagliflozin
Labeler
lexicon pharmaceuticals, inc.
Dosage Form
TABLET
Routes
Active Ingredients
sotagliflozin 200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
70183-221
Product ID
70183-221_cd790640-aade-49e0-a549-6eac00d3efc2
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA216203
Listing Expiration
2027-12-31
Marketing Start
2023-05-26
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
70183221
Hyphenated Format
70183-221
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
inpefa (source: ndc)
Generic Name
sotagliflozin (source: ndc)
Application Number
NDA216203 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/1
Packaging
- 1 BLISTER PACK in 1 CARTON (70183-221-07) / 7 TABLET in 1 BLISTER PACK
- 30 TABLET in 1 BOTTLE (70183-221-30)
- 1 BLISTER PACK in 1 CARTON (70183-221-31) / 3 BLISTER PACK in 1 BLISTER PACK / 10 TABLET in 1 BLISTER PACK
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "cd790640-aade-49e0-a549-6eac00d3efc2", "openfda": {"nui": ["N0000187059", "N0000187058", "N0000185503"], "upc": ["0370183221302", "0300000000001", "0370183241300"], "unii": ["6B4ZBS263Y"], "rxcui": ["2638683", "2638689", "2638691", "2638693"], "spl_set_id": ["1a46614e-05f6-421a-b6f4-d6f8760d643a"], "pharm_class_epc": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"], "pharm_class_moa": ["Sodium-Glucose Transporter 2 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Lexicon Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": true, "description": "1 BLISTER PACK in 1 CARTON (70183-221-07) / 7 TABLET in 1 BLISTER PACK", "package_ndc": "70183-221-07", "marketing_start_date": "20240115"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (70183-221-30)", "package_ndc": "70183-221-30", "marketing_start_date": "20240301"}, {"sample": false, "description": "1 BLISTER PACK in 1 CARTON (70183-221-31) / 3 BLISTER PACK in 1 BLISTER PACK / 10 TABLET in 1 BLISTER PACK", "package_ndc": "70183-221-31", "marketing_start_date": "20231201"}], "brand_name": "INPEFA", "product_id": "70183-221_cd790640-aade-49e0-a549-6eac00d3efc2", "dosage_form": "TABLET", "pharm_class": ["P-Glycoprotein Inhibitors [MoA]", "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "product_ndc": "70183-221", "generic_name": "sotagliflozin", "labeler_name": "Lexicon Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "INPEFA", "active_ingredients": [{"name": "SOTAGLIFLOZIN", "strength": "200 mg/1"}], "application_number": "NDA216203", "marketing_category": "NDA", "marketing_start_date": "20230526", "listing_expiration_date": "20271231"}